| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 10/09/2013 | EP2646446A2 Bromodomain inhibitors and uses thereof |
| 10/09/2013 | EP2646445A1 Oxazolo [5, 4 -b]pyridin- 5 -yl compounds and their use for the treatment of cancer |
| 10/09/2013 | EP2646440A2 Hybrid cyclic libraries and screens thereof |
| 10/09/2013 | EP2646433A1 Pyrimidine compound and use for pest control thereof |
| 10/09/2013 | CN103347884A Pyrazino[2,3-d]isooxazole derivative |
| 10/09/2013 | CN103342700A 11[beta]-hydroxysteroid dehydrogenase type 1 inhibitor |
| 10/08/2013 | US8552187 Processes and intermediates for carbamoylpyridone HIV integrase inhibitors |
| 10/08/2013 | US8551522 Sustained-release formulation |
| 10/08/2013 | CA2667826C Inhibitors of histone deacetylase |
| 10/08/2013 | CA2604071C Antipruritic agent for pruritus caused by multiple sclerosis |
| 10/03/2013 | WO2013148874A1 Anti-inflammatory macrolides |
| 10/03/2013 | WO2013147026A1 Aromatic ring compound |
| 10/03/2013 | US20130261296 Catalyst complex with carbene ligand |
| 10/03/2013 | US20130261107 Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mglur5 receptors |
| 10/03/2013 | US20130261081 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine |
| 10/02/2013 | CN103333246A Anti-EGFR tumor growth inhibitor, preparation method thereof and applications thereof |
| 10/02/2013 | CN103333179A Maytansinoid derivatives, preparation method thereof and applications thereof |
| 10/02/2013 | CN102046637B Crystalline form of n-[[4-fluoro-2-(5-methyl-1h-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide, sodium salt monohydrate |
| 10/01/2013 | US8546422 Azaindole derivatives as CRTH2 receptor antagonists |
| 10/01/2013 | US8546376 Pharmaceutical compounds |
| 10/01/2013 | US8545550 Drug-delivery endovascular stent and method for treating restenosis |
| 10/01/2013 | CA2720516C Indoline anti-cancer agents |
| 09/26/2013 | WO2013142307A1 Carbamate compounds and of making and using same |
| 09/26/2013 | WO2013140348A1 Compounds for the treatment of ischemia-reperfusion- related diseases |
| 09/26/2013 | WO2013139697A1 Conformationally constrained, fully synthetic macrocyclic compounds |
| 09/26/2013 | US20130253000 Treatment of solid tumors with rapamycin derivatives |
| 09/26/2013 | US20130252962 Spiro-oxindole compounds and their use as therapeutic agents |
| 09/26/2013 | US20130252961 Macrocyclic derivatives for the treatment of diseases |
| 09/26/2013 | US20130252943 Bicyclic oxazole lactams as allosteric modulators of mglur5 receptors |
| 09/25/2013 | EP2640730A1 Processes for preparation of everolimus and intermediates thereof |
| 09/25/2013 | CN103319501A Four-functional spiro(fluorene-xanthene)benzoxazine |
| 09/25/2013 | CN103319500A Novel benzodiazepine sedative hypnotic drug |
| 09/25/2013 | CN103319456A Dihydropyridine compounds, and compositions, preparation methods and applications thereof |
| 09/25/2013 | CN102443011B Levorotatory fluoroquinolone C3 diazole methyl sulfide quaternary ammonium salt, preparation method and application thereof |
| 09/25/2013 | CN102006776B Harmful arthropod control composition, and fused heterocyclic compound |
| 09/24/2013 | US8541599 Supports for oligomer synthesis |
| 09/24/2013 | US8541573 Substituted sulfonamide compounds |
| 09/24/2013 | US8541444 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| 09/24/2013 | CA2755554C Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 09/24/2013 | CA2568914C Therapeutic agents, and methods of making and using the same |
| 09/19/2013 | US20130245264 Pyrazino[2,3-d]isoxazole derivative |
| 09/19/2013 | US20130245256 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 09/19/2013 | US20130245254 Methods of synthesis and purification of heteroaryl compounds |
| 09/19/2013 | US20130245048 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof |
| 09/19/2013 | US20130245022 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/19/2013 | US20130245009 Novel compounds |
| 09/19/2013 | US20130244951 Treatment of solid tumors with rapamycin derivatives |
| 09/18/2013 | EP2639235A1 Pyrazino[2,3-d]isooxazole derivative |
| 09/18/2013 | EP2638048A1 Nucleic acidsbuilding blocks and methods for the synthesis of 5-hydroxymethylcytosine-containing |
| 09/18/2013 | EP2637660A1 Fatty acid synthase inhibitors |
| 09/18/2013 | CN103313992A Hdac inhibiting derivatives of camptothecin |
| 09/18/2013 | CN103313989A Tricyclic PI3K inhibitor compounds and methods of use |
| 09/18/2013 | CN103304579A ortho-positioned bridged azacrown ether modified phthalocyanin and preparation method and application thereof |
| 09/18/2013 | CN103304578A Spirofluorene xanthenes bisphenol type benzoxazine |
| 09/18/2013 | CN102174042B 免疫抑制剂化合物和组合物 Immunosuppressive compounds and compositions |
| 09/17/2013 | US8536339 AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
| 09/17/2013 | US8536327 Epothilone derivatives |
| 09/17/2013 | US8536164 Fused pyridine compounds as casein kinase inhibitors |
| 09/17/2013 | US8535655 Biodegradable polymer—bioactive moiety conjugates |
| 09/12/2013 | WO2013134527A1 Synthesis of polycyclic alkaloids and their use as tgr5 agonists |
| 09/12/2013 | WO2013133556A1 Novel triazolo pyridazine derivative and use therefor |
| 09/12/2013 | WO2013132380A1 Thiazole derivatives as alpha 7 nachr modulators |
| 09/12/2013 | WO2013132376A1 Macrocyclic derivatives for the treatment of proliferative diseases |
| 09/12/2013 | US20130237535 Fatty acid synthase inhibitors |
| 09/12/2013 | US20130237523 Acrylamide derivatives as fab i inhibitors |
| 09/12/2013 | US20130237521 Imidazopyrizine syk inhibitors |
| 09/12/2013 | US20130237520 Imidazopyrazine syk inhibitors |
| 09/11/2013 | EP2635587A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors |
| 09/11/2013 | CN103288849A Mixed amine-based multi-functionality fluorenyl benzoxazine and synthesis method thereof |
| 09/11/2013 | CN102086211B Aromatic heterocyclic compounds serving as protein kinase inhibitor |
| 09/11/2013 | CN101815713B Polycyclic compound |
| 09/10/2013 | US8530505 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/10/2013 | US8530483 Substituted azabenzoxazoles |
| 09/10/2013 | CA2574301C (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 09/10/2013 | CA2561014C Thioamide derivatives as progesterone receptor modulators |
| 09/06/2013 | WO2013130890A1 Heterobicyclic compounds and their use as phosphodiesterase inhibitors |
| 09/06/2013 | WO2013130855A1 Indazole derivatives |
| 09/05/2013 | US20130231353 Pyrido- and pyrimidopyrimidine derivatives as anti-profilerative agents |
| 09/05/2013 | US20130231331 Inhibitors of Human Immunodeficiency Virus Replication |
| 09/04/2013 | EP2634177A1 Tau imaging probe |
| 09/04/2013 | CN103282362A Hybrid cyclic libraries and screens thereof |
| 09/04/2013 | CN103275067A Inhibitors of histone deacetylase |
| 09/04/2013 | CN102850376B One-step synthesizing method of levofloxacin and ofloxacin |
| 09/04/2013 | CN101679339B Method for manufacturing neuraminic acid derivatives |
| 09/03/2013 | US8524893 Process for the preparation of temsirolimus and its intermediates |
| 09/03/2013 | US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors |
| 09/03/2013 | US8524708 Oxadiazoanthracene compounds for the treatment of diabetes |
| 08/29/2013 | US20130225823 Processes for preparation of everolimus and intermediates thereof |
| 08/29/2013 | US20130225624 Bicyclic heterocyclic spiro compounds |
| 08/29/2013 | US20130225558 Fused tetracyclic pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use |
| 08/29/2013 | US20130225552 Heterobicyclic compounds |
| 08/29/2013 | US20130225549 Dihydropteridinones i |
| 08/28/2013 | EP2631238A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections |
| 08/28/2013 | CN103265559A Substituted tricyclo-quinone compounds, and preparation method and application thereof |
| 08/28/2013 | CN102268015B Synthesis method of everolimus |
| 08/28/2013 | CN101998959B Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 08/27/2013 | US8518983 P38 inhibitors and methods of use thereof |
| 08/27/2013 | US8518949 Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 08/27/2013 | US8518937 Pyrimidinediamine kinase inhibitors |
| 08/27/2013 | CA2678754C Process for the preparation and purification of thiol-containing maytansinoids |